Researcher hopes to make gene-editing device safer and more precise

By: Jan Jarvis

Crispr Web

The mere mention of gene editing and DNA altering might conjure up images of designer babies, but that is not what researcher Jin Liu has in mind.

She wants help to find a cure for life-threatening diseases by making the gene-editing device CRISPR-Cas9 safer and more precise.

“Any genetic disease, the CRISPR-Cas9 technology has the potential to cure,” Dr. Liu said. “Cancer, eye diseases and sickle cell anemia for example.”

The CRISPR-Cas9 system allows researchers to make changes in a cell’s genetic code. The Cas9 enzyme is used to cut the DNA. But there is a problem standing in the way of successfully finding the cut position and altering the gene, said Dr. Liu, Assistant Professor of Pharmaceutical Sciences.

“When something is wrong with the DNA we can cut it out and repair it,” she said “But to bring the technology to the therapeutic field we have to be able to cut the DNA as accurately as possible.”

Finding a way to cut into the DNA with specificity is one of the goals that Dr. Liu wants to achieve with the help of a $437,864 National Institute of Health/National Heart Lung and Blood Institute grant.

When DNA is in the wrong place, it is called “off-target effects.”

“The goal is to reduce the off-target effects and increase the on-target effects,” she said. “You only want the DNA modification to be on-target.”

Using computer models to simulate how Cas9 enzyme interacts with DNA, Dr. Liu is working to better understand the mechanisms behind the off target effects.

“If we can figure that out, then we can understand the modifications that need to be made to eliminate undesirable results,” she said. “We can design a new enzyme that cuts DNA precisely.”

The next step is to test the approach in the lab to see if it performs as well as expected. Eye diseases will probably be the first model tested, Dr. Liu said. The technology could one day be used to cure lymphoma, HIV and sickle cell disease.

“There’s a lot of potential with this technology,” she said, “Many diseases could be cured.”

Recent News

Screenshot
  • Community
|May 22, 2025

From the arts to anatomy: Gwen Moores finds purpose in medicine

Gwen Moores found her calling during the pandemic. After completing an undergraduate degree in German and working abroad in German theaters and opera houses—followed by a stint in financial services in the U.S.—she felt pulled in a completely new direction: medicine. “Since I hadn’t c...
Bus By Courthouse 2
  • Our People
|May 21, 2025

Design on the move: UNTHSC wins transit award for public ad

The University of North Texas Health Science Center at Fort Worth’s Office of Marketing and Communications received the Adsposure award for Best Impact in this year’s Transit Awards. This recognition underscores the power of creativity and strategic messaging in public spaces. For the p...
Adobestock 560072776 (1)
  • Community
|May 20, 2025

American Osteopathic Association, SaferCare Texas launch resources to combat workplace violence in healthcare

To address the growing threat of workplace violence in healthcare, the American Osteopathic Association and SaferCare Texas have developed a comprehensive resource guide and online course to help healthcare professionals recognize, prevent and respond to violent incidents. Workplace violence in h...
Pharmacy Research
  • Community
|May 19, 2025

UNT System Board of Regents approves fall 2026 Ph.D. in Pharmaceutical Sciences at UNTHSC

A new Ph.D. in Pharmaceutical Sciences, the first degree of its kind offered in the Dallas-Fort Worth Metroplex, will tentatively be offered starting in fall 2026 at The University of North Texas Health Science Center at Fort Worth. The new doctoral degree in UNTHSC’s College of Pharmacy was ap...